新生儿在线过滤效果:新生儿静脉中心通路安全(INCAS)随机对照试验研究方案
该多中心随机单盲对照试验拟纳入需延长输注治疗的新生儿重症监护病房(NICU)患儿,随机分为过滤器组或对照组,主要结局为至少发生一次脓毒症样事件(疑似脓毒症症状伴C反应蛋白(CRP)>5 mg/L且培养阴性)的患者频率,每臂样本量计算为368例。
要点
- 在线过滤器可去除成人及年长婴儿输注中的微生物、内毒素、空气和颗粒,但在新生儿中的获益尚待证实。
- 主要结局为至少一次脓毒症样事件(疑似脓毒症症状伴CRP>5 mg/L且培养阴性)的患者频率。
- 若在线过滤器显著减少脓毒症样事件和/或其他并发症,可考虑在NICU所有静脉给药系统中推荐使用在线过滤器。
核心结论
- 这是首个比较肠外营养及其他静脉药物在线过滤与无过滤器输注的多中心随机对照试验。
- 若在线过滤器显著减少脓毒症样事件和/或其他并发症,可考虑在NICU所有静脉给药系统中推荐使用在线过滤器。
研究设计与样本
- 多中心随机单盲对照试验,纳入NICU中预期需延长输注治疗的患儿,随机分为过滤器组或对照组。
- 所有患者监测至出院,数据按「全分析集」分析。
- 每臂样本量计算为368例。
主要发现
- 目标人群中脓毒症样事件的风险估计为30-35%,但该数据未在文献中得到证实。
- NICU中50%的炎症事件血培养阴性,这些事件可能部分与输注管路中颗粒的存在有关。
关键数值与推荐
- 主要结局为至少发生一次脓毒症样事件(疑似脓毒症症状伴CRP>5 mg/L且培养阴性)的患者频率。
- 次要结局包括脓毒症、静脉炎、管腔阻塞的频率以及机械通气时长和导管留置天数。
临床怎么用
- 原文未据此给出推荐。
局限性
- 目标人群中脓毒症样事件的风险估计为30-35%,但该数据未在文献中得到证实。
- 在线过滤器在新生儿中的获益尚待证实。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Particulate contamination due to infusion therapy (administration of parenteral nutrition and medications) carries a potential health risk for infants in neonatal intensive care units (NICUs). This particulate consists of metals, drug crystals, glass fragments, or cotton fibers and can be generated by drug packaging, incomplete reconstitution, and chemical incompatibilities. In-line filters have been shown to remove micro-organisms, endotoxin, air, and particles in critically ill adults and older infants, but its benefits in newborn remain to be demonstrated. Moreover, 50% of inflammatory episodes in the setting of NICUs are blood culture-negative. These episodes could be partly related to the presence of particles in the infusion lines. METHODS: A multicenter randomized single-blind controlled trial was designed. All infants admitted to NICUs for which prolonged infusion therapy is expected will be enrolled in the study and randomized to the Filter or Control arm. All patients will be monitored until discharge, and data will be analyzed according to a "full analysis set." The primary outcome is the frequency of patients with at least one sepsis-like event, defined by any association of suspected sepsis symptoms with a level of c-reactive protein (CRP) > 5 mg/L in a negative-culture contest. The frequency of sepsis, phlebitis, luminal obstruction, and the duration of mechanical ventilation and of catheter days will be evaluated as secondary outcomes. The sample size was calculated at 368 patients per arm. DISCUSSION: This is the first multicenter randomized control trial that compares in-line filtration of parenteral nutrition and other intravenous drugs to infusion without filters. Sepsis-like events are commonly diagnosed in clinical practice and are more frequent than sepsis in a positive culture contest. The risk of these episodes in the target population is estimated at 30-35%, but this data is not confirmed in the literature. If the use of in-line filters results in a significant decrease in sepsis-like events and/or in any other complications, the use of in-line filters in all intravenous administration systems may be recommended in NICUs. TRIAL REGISTRATION: ClinicalTrials.gov, NCT05537389, registered on 12 September 2022 ( https://classic. CLINICALTRIALS: gov/ct2/show/results/NCT05537389?view=results ).
引用
- Cresi F, Maggiora E, Capetti C, et al. Effect of in-line filtration in newborns: study protocol of the Intravenous Neonatal Central Access Safety (INCAS) randomized controlled trial. Trials. 2024. PMID: 38971756. doi:10.1186/s13063-024-08264-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。